Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
1-(4-Fluorophenyl)-1h-indole-5-carboxylic acid → 4-(1-{[1-(4-Fluorophenyl)-1H-indol-5-yl]carbonyl}azetidin-3-yl)-1-pyrimidin-2-ylpiperazin-2-one
참여 물질
| 역할 | 이름 | HCID | 투입량 |
|---|---|---|---|
| 반응물 | 1-(4-Fluorophenyl)-1h-indole-5-carboxylic acid | HCID 22603071 | — |
| 반응물 | 3-(3-Oxo-4-pyrimidin-2-yl-piperazin-1-yl)-azetidine-1-carboxylic acid tert-butyl ester | HCID 66836249 | — |
| 생성물 | 4-(1-{[1-(4-Fluorophenyl)-1H-indol-5-yl]carbonyl}azetidin-3-yl)-1-pyrimidin-2-ylpiperazin-2-one | HCID 66823546 | — |
반응 단계
Cpd 4 was prepared according to the procedures described in Example 2, Step D, using intermediates 3c and 1-(4-fluoro-phenyl)-1H-indole-5-carboxylic acid 3h as starting materials. MS 471 (M+H+).
출처 및 근거
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| 특허 번호 | US08637498B2 |
| 출처 데이터셋 | uspto-grants-2014_01 |
| ORD ID | ord-5eacd61f07dd4dbc975932ebc478116b |
| 출처 메모 | uspto-grants-2014_01 |